Contagious Mastitis (S. agalactiae, S. aureus)

Contagious mastitis represents one of the most economically significant infectious disease categories affecting dairy cattle worldwide, characterized by transmission from infected to uninfected cows primarily during the milking process. The two principal pathogens causing contagious mastitis are Streptococcus agalactiae and Staphylococcus aureus, organisms that have adapted to survive within the bovine mammary gland and spread efficiently between animals through contaminated milking equipment, milkers' hands, and shared towels or equipment. Unlike environmental mastitis pathogens that originate from bedding and surroundings, contagious pathogens reside primarily in infected udders and are transmitted during milking when bacteria from infected quarters contaminate milking units, teat cup liners, or surfaces that subsequently contact uninfected teats.

Streptococcus agalactiae is an obligate mammary pathogen that cannot survive for extended periods outside the udder, making it theoretically eradicable from dairy herds through systematic identification and treatment or culling of infected animals combined with improved milking hygiene. This organism was historically the most common cause of mastitis and elevated somatic cell counts but has been successfully eliminated from many modern dairy herds through aggressive control programs. Staphylococcus aureus presents greater challenges due to its ability to survive in the environment, establish chronic deep-tissue infections that are difficult to cure, and develop antimicrobial resistance. While S. agalactiae rarely causes severe clinical disease, S. aureus can cause a spectrum from subclinical infection to acute gangrenous mastitis.

The economic impact of contagious mastitis is substantial and multifaceted. Subclinical infections with these organisms cause persistent elevations in somatic cell count that may result in milk quality penalties, rejection of milk shipments, and loss of premium pricing. Clinical mastitis episodes result in discarded milk, treatment costs, and production losses. The chronic nature of many S. aureus infections leads to progressive udder damage and declining productivity over successive lactations. Premature culling of chronically infected animals represents a significant cost, particularly when high-value genetics are involved. Herd-level infection prevalence directly impacts profitability, with heavily infected herds facing substantially reduced net returns.

Control of contagious mastitis requires sustained commitment to comprehensive mastitis control programs incorporating milking hygiene, post-milking teat disinfection, treatment of clinical cases, dry cow therapy, and strategic culling of chronically infected animals. The five-point mastitis control plan developed decades ago specifically targeted contagious pathogens and remains foundational to modern mastitis control programs. Successful herds have achieved virtual elimination of S. agalactiae and dramatic reduction in S. aureus prevalence. Early detection through regular somatic cell count monitoring and periodic culture surveys allows identification of infected animals before widespread transmission occurs. Prevention is more effective and economical than treatment, particularly for S. aureus infections.

The primary causative agents of contagious mastitis are Streptococcus agalactiae and Staphylococcus aureus, gram-positive bacteria that have evolved specialized adaptations for survival and transmission within the dairy environment. Streptococcus agalactiae, also known as Group B Streptococcus, is an obligate pathogen of the bovine mammary gland that does not survive well in the environment and depends entirely on infected udders for its reservoir. This organism colonizes the milk ducts and teat cistern, producing chronic subclinical infections characterized by markedly elevated somatic cell counts. Staphylococcus aureus is a more versatile pathogen capable of surviving on skin, in the environment, and within deep mammary tissue where it forms microabscesses that protect bacteria from antimicrobials and immune responses.

While contagious mastitis itself is not hereditary, genetic factors influence susceptibility to infection and ability to clear established infections. Research has identified genetic variations in immune response genes, teat and udder conformation traits, and milk protein variants that correlate with mastitis resistance or susceptibility. Heritability estimates for clinical mastitis range from five to fifteen percent, indicating that while environmental factors dominate, genetic selection can meaningfully impact mastitis rates over generations. Somatic cell score is moderately heritable at approximately ten to fifteen percent and serves as an indirect indicator of subclinical mastitis. Breeding programs incorporating health traits alongside production can reduce herd susceptibility to contagious pathogens.

Transmission of contagious mastitis pathogens occurs primarily during the milking process through several mechanisms. Milking units become contaminated when attached to infected quarters, and bacteria are then transferred to subsequent cows milked with the same unit. Teat cup liners harbor bacteria in cracks and irregularities, particularly as liners age and rubber deteriorates. Milkers' hands carry bacteria between cows when gloves are not changed or proper hygiene is not observed. Common towels or udder wash cloths spread infection efficiently if not used for single animals only. Milk splashing and backflow during milking can propel contaminated milk onto teats of uninfected quarters.

Risk factors for contagious mastitis acquisition include both management practices and individual animal characteristics. Milking order affects exposure, with cows milked after known infected animals facing higher risk. Poor milking equipment maintenance including improper vacuum levels, pulsation abnormalities, and worn liners damages teats and facilitates bacterial invasion. Inadequate pre-milking teat preparation fails to remove bacteria present on teats before unit attachment. Absence of post-milking teat disinfection allows bacteria deposited during milking to penetrate the teat canal. Previous mastitis episodes, teat injuries, and poor teat end condition increase susceptibility. High-producing cows may face elevated risk due to immune suppression and more frequent milking.

The pathophysiology of contagious mastitis differs between the two primary pathogens. Streptococcus agalactiae colonizes the teat canal and cistern, producing toxins and enzymes that damage milk-secreting tissue and trigger inflammatory response. The infection typically remains in the ductal system rather than invading deep parenchyma, which contributes to good treatment response. Staphylococcus aureus invades deeper into mammary tissue, forming microabscesses surrounded by fibrous capsules that wall off bacteria from antimicrobials and immune cells. This pathogen can persist intracellularly within macrophages and may remain dormant for extended periods before recrudescing. The biofilm-forming capacity of S. aureus further protects bacteria and explains the poor cure rates achieved with treatment.

Early warning signs of contagious mastitis infection may be extremely subtle, as many cases remain subclinical for extended periods with no visible abnormalities in milk or udder. Elevated individual cow somatic cell counts detected through regular testing may provide the first indication of new infection. Slight changes in milk conductivity detected by automated milking systems can identify quarters with developing inflammation. Minor changes in milk appearance including small flakes or clots may be overlooked during routine milking if foremilk is not stripped and examined. Slight firmness or asymmetry in quarter size may be detectable on careful palpation. Reduced milk yield from specific quarters relative to others suggests possible infection.

Clinical symptoms when they occur vary considerably between pathogens and between individual cases. Streptococcus agalactiae typically causes mild clinical mastitis with slight swelling, mildly abnormal milk containing flakes or clots, and minimal systemic signs. Episodes may resolve spontaneously only to recur, maintaining chronic subclinical infection between clinical flares. Staphylococcus aureus presentations range from mild clinical mastitis similar to S. agalactiae through moderate disease with noticeable udder swelling and clearly abnormal milk to rare peracute gangrenous cases with severe systemic illness. Most S. aureus infections persist subclinically for extended periods with intermittent mild clinical flares.

Behavioral changes associated with contagious mastitis are often subtle or absent in subclinical cases. Cows with clinical mastitis may show mild discomfort during milking, with slight reluctance to enter the parlor or positioning to protect affected quarters. Decreased appetite is generally mild unless severe clinical disease develops. Activity level remains normal in most cases. Milk let-down may be impaired in painful quarters. Isolation from herdmates is uncommon with typical subclinical or mild clinical presentations. Behavioral signs are more useful for detecting acute clinical episodes than identifying the more common chronic subclinical infections.

Physical examination findings depend on infection stage and severity. In subclinical infection, physical examination may reveal no abnormalities whatsoever, with elevated somatic cell count being the only indicator. Mild clinical cases show slight quarter swelling, warmth, and firmness on palpation with mildly abnormal milk containing flakes, clots, or slight discoloration. Moderate clinical mastitis presents with obvious quarter swelling, marked milk abnormalities, and mild systemic signs including slight fever and decreased appetite. Chronic S. aureus infections may produce fibrotic hardening of the quarter detectable as firm nodular tissue on deep palpation. Teat end condition including hyperkeratosis often correlates with infection risk.

Symptom progression in untreated contagious mastitis typically involves development of chronic subclinical infection interspersed with clinical flares rather than continuous acute disease. Streptococcus agalactiae infections persist indefinitely without treatment but rarely progress to severe clinical disease. Staphylococcus aureus causes progressive tissue damage over successive lactations, with affected quarters showing declining production and increasing firmness. Clinical episodes tend to recur at irregular intervals, often associated with stressors or management changes. Some S. aureus strains can cause acute severe mastitis, particularly in naive animals or when high bacterial loads are suddenly introduced.

Emergency symptoms requiring immediate veterinary attention are relatively uncommon with contagious mastitis but include signs of peracute or gangrenous mastitis. Rapid onset of severe systemic illness with high fever, profound depression, and anorexia suggests either extremely virulent infection or misdiagnosis of an environmental pathogen. Cold, discolored quarter tissue indicates gangrenous change requiring immediate intervention. Bloody or foul-smelling secretions from affected quarters warrant urgent evaluation. Recumbency, dehydration, and shock signs indicate severe toxemia. Complete cessation of milk flow from the affected quarter may indicate complete duct blockage or severe tissue damage. Any rapid deterioration in a cow previously diagnosed with mastitis requires reassessment.

Clinical examination for contagious mastitis includes systematic evaluation of all four quarters regardless of clinical signs, recognizing that subclinical infections are common and may involve multiple quarters. Visual inspection and palpation assess quarter size symmetry, tissue consistency, warmth, and pain response. Comparison between quarters often reveals subtle differences indicating unilateral infection. Teat end condition is evaluated for hyperkeratosis, injuries, or other lesions that increase infection risk. Foremilk from each quarter is stripped onto a dark surface or paddle to assess color, consistency, and presence of clots or flakes. California Mastitis Test provides rapid estimation of somatic cell content, with positive reactions indicating inflammation consistent with infection.

Diagnostic testing provides definitive pathogen identification essential for appropriate treatment and control decisions. Milk samples collected aseptically from affected quarters before antimicrobial treatment yield the most accurate culture results. Standard laboratory culture identifies S. agalactiae within twenty-four to forty-eight hours based on characteristic colony morphology and biochemical reactions. Staphylococcus aureus identification requires confirmation of coagulase production to differentiate from less pathogenic coagulase-negative staphylococci. Antimicrobial susceptibility testing guides treatment selection, though results must be interpreted cautiously for S. aureus given poor correlation between in vitro susceptibility and in vivo cure rates. On-farm culture systems using selective media allow presumptive identification within twenty-four hours.

Differential diagnosis for suspected contagious mastitis includes other bacterial pathogens causing similar presentations. Streptococcus dysgalactiae and Streptococcus uberis are environmental streptococci that may initially appear similar to S. agalactiae but do not share its contagious transmission pattern. Coagulase-negative staphylococci cause subclinical mastitis with elevated cell counts but are generally less pathogenic than S. aureus. Mycoplasma species cause contagious mastitis that requires special culture techniques for detection. Corynebacterium bovis inhabits the teat canal and may cause mild cell count elevations. Culture remains essential for distinguishing between pathogens with different epidemiology, treatment responses, and control implications.

Herd-level diagnostic evaluation identifies the scope of infection and guides control program development. Bulk tank culture provides rapid screening for S. agalactiae presence in the herd and semiquantitative assessment of S. aureus prevalence. Monthly individual cow somatic cell count data from DHIA testing identifies high-count animals warranting culture. Strategic culture of fresh heifers, recent purchases, and clinical cases provides ongoing surveillance. Comprehensive herd culture surveys establish true prevalence and identify all infected animals. Analysis of mastitis records including pathogen distribution, new infection timing, and cure rates helps identify transmission patterns. Linear score trends over time reflect program effectiveness.

Treatment approaches differ substantially between S. agalactiae and S. aureus infections, reflecting major differences in pathophysiology and cure rates. Streptococcus agalactiae is highly susceptible to antimicrobial therapy, with cure rates exceeding ninety percent achievable using approved intramammary antibiotics. Standard lactating cow intramammary therapy administered according to label directions is usually curative. Extended therapy protocols may slightly improve cure rates but must be balanced against increased withdrawal times and costs. Treatment of all infected quarters in the herd, combined with improved milking hygiene, can achieve complete elimination of S. agalactiae within a single lactation. Cost-benefit analysis almost universally favors aggressive treatment given high cure rates and ongoing production losses from infected quarters.

Staphylococcus aureus treatment presents much greater challenges with cure rates typically ranging from only fifteen to thirty-five percent for lactating cow therapy. Extended intramammary therapy protocols using five to eight days of treatment improve cure rates modestly compared to standard label duration. Combination therapy using both intramammary and systemic antimicrobials may enhance outcomes, particularly for recent infections. Treatment success is influenced by numerous factors including infection duration, cow age, somatic cell count level, number of quarters infected, and bacterial strain characteristics. Treatment costs and extended withdrawal periods must be weighed against limited success probability and continued production losses during treatment.

Dry cow therapy represents the most effective treatment opportunity for contagious mastitis pathogens. The extended contact time between antimicrobial and bacteria during the non-lactating period substantially improves cure rates for both pathogens. Staphylococcus aureus cure rates with dry cow therapy reach forty to sixty percent in selected cases, roughly double lactating cow treatment success. All quarters should receive dry cow therapy regardless of infection status to treat existing infections and prevent new ones. Extended-duration dry cow products provide protection throughout the dry period. Internal teat sealants combined with antibiotic therapy provide both treatment and prevention benefits.

Supportive care considerations for contagious mastitis are generally minimal given the typically mild clinical presentation. Frequent milking of affected quarters may help clear infection and reduce cell counts. Anti-inflammatory therapy is rarely needed except for more severe clinical flares. Nutritional support maintaining immune function aids treatment response. Rest from intensive production demands by drying off chronically infected quarters may allow tissue healing. Pain management is seldom necessary. The primary focus remains antimicrobial therapy and preventing further transmission rather than intensive nursing care required for severe environmental mastitis.

Herd treatment protocols must balance individual animal treatment with population-level control strategies. Identification of all infected animals through culture surveys allows targeted treatment decisions. Fresh infections detected within the first few weeks offer better prognosis than chronic established cases. Treatment selection algorithms consider pathogen identity, infection duration, cow value, and probability of success. Some protocols reserve lactating cow treatment for recent S. aureus infections with favorable prognostic factors while deferring chronic cases to dry cow therapy or culling. Standard operating procedures define treatment protocols, withdrawal tracking, and decision criteria for veterinary consultation.

Treatment decisions for S. aureus-infected cows often involve economic calculations weighing treatment costs against alternatives. Factors influencing treatment-versus-cull decisions include cow age and remaining productive life, production level and genetic value, number and which quarters are infected, somatic cell count history, herd prevalence and control program goals, and replacement costs. Young high-producing cows with single-quarter recent infections warrant treatment attempts. Older multiparous cows with chronic multi-quarter infections and high cell counts are often better candidates for culling. Segregation of infected cows to be milked last while awaiting culling reduces new infections. Veterinary consultation helps optimize these complex decisions.

Recovery timeline for contagious mastitis varies dramatically based on pathogen, treatment response, and infection chronicity. Streptococcus agalactiae infections typically respond within several days of initiating treatment, with milk appearance normalizing and somatic cell counts declining over two to four weeks. Follow-up culture at two to three weeks post-treatment confirms bacteriological cure. Complete resolution allows return to normal production from the affected quarter. Staphylococcus aureus recovery when cure is achieved follows a similar timeline, but treatment failure is common and must be monitored through follow-up testing. Chronic infections that fail to clear result in ongoing subclinical mastitis with elevated cell counts and progressive tissue damage.

Post-treatment care and monitoring are essential for confirming cure and detecting treatment failures. Somatic cell count testing at the next scheduled DHIA test provides initial indication of treatment response. Counts declining into the normal range suggest cure, while persistently elevated counts indicate ongoing infection. Culture of milk samples from treated quarters at two to four weeks post-treatment provides definitive confirmation. The treated quarter should be monitored for recurrence of clinical signs over several subsequent months. For S. aureus, some animals may test negative initially only to have positive cultures detected later, indicating persistence of deep-tissue infection.

Prognosis factors for treatment success are well-characterized, particularly for S. aureus infections. Infection duration strongly predicts outcome, with recent infections showing dramatically better cure rates than chronic cases established for multiple lactations. Younger cows in early lactations respond better than older cows. Lower pre-treatment somatic cell counts correlate with higher cure probability. Single quarter infections carry better prognosis than multiple quarter involvement. Certain S. aureus strains including those producing beta-lactamase or demonstrating small colony variant phenotypes are more resistant to treatment. Teat end condition and milking equipment function affect both cure rates and new infection risk.

Return to production following successful cure allows normal function of previously infected quarters. Quarters that achieve bacteriological cure typically show gradual improvement in production over subsequent weeks as tissue damage heals. Somatic cell counts return to normal levels, eliminating quality penalties. Future mastitis susceptibility may remain slightly elevated in previously infected quarters. For cows that fail treatment, decisions regarding continued production with subclinical infection, segregation within the herd, dry-off of affected quarters, or culling must be made. Quarters with extensive fibrotic damage from chronic S. aureus infection may never return to normal production even if infection is eventually cleared.

Vaccination for contagious mastitis pathogens offers limited protection, with available vaccines generally reducing disease severity rather than preventing infection. Staphylococcus aureus vaccines based on various bacterial components have shown modest efficacy in some studies, reducing new infection rates and clinical severity. No S. agalactiae-specific vaccines are available, though control is readily achievable through management and treatment without vaccination. Vaccination may serve as one component of comprehensive control programs but cannot substitute for fundamental milking hygiene and treatment protocols. Cost-benefit analysis should consider limited efficacy against vaccination and booster costs.

Biosecurity measures for contagious mastitis focus on preventing introduction of infected animals and limiting within-herd transmission. Purchased animals should be cultured before introduction and held separately until confirmed negative or treated successfully. Fresh heifers entering the milking herd may harbor infections acquired from contact with infected dry cows or from suckling infected dams. Milking order protocols position known infected cows last, reducing transmission to uninfected animals. Separate milking units designated for infected cows prevent mechanical transmission. Hospital strings of treated or infected cows should be maintained and milked last. Movement of personnel between farms should consider potential pathogen transfer on clothing and equipment.

Milking hygiene forms the foundation of contagious mastitis prevention. Pre-milking teat preparation including cleaning and drying removes bacteria from teat surfaces before unit attachment. Forestripping detects clinical mastitis and removes bacteria-laden canal milk. Single-use towels prevent cross-contamination between cows. Proper unit attachment and alignment minimizes teat end impacts that damage sphincter function. Automatic takeoff at appropriate flow thresholds prevents overmilking. Post-milking teat disinfection with proven germicides kills bacteria deposited during milking before they can penetrate the teat canal. Dip must contact entire teat surface and remain until dry.

Equipment maintenance directly impacts transmission risk and teat health. Vacuum levels must be appropriate for the system and cow type, with excessive vacuum damaging teats. Pulsation timing and ratio ensure adequate rest and massage phases. Liner condition deteriorates with use, and replacement schedules should be followed based on milkings or time in use. Rubber liners develop cracks that harbor bacteria and should be replaced before visible deterioration. Silicone liners offer longer life but higher initial cost. Claw pieces and milk lines must be maintained and cleaned effectively. Regular milking system evaluation by qualified technicians identifies developing problems.

Quarantine and testing protocols play important roles in contagious mastitis control programs. New animal purchases represent the primary route of new pathogen introduction to closed herds. Pre-purchase culture or extended post-arrival quarantine with testing protects herd status. Heifers freshening from off-site heifer rearing facilities should be screened. Animals returning from shows or sales warrant testing. Regular surveillance through bulk tank culture and individual cow monitoring detects new infections before widespread transmission. Response protocols for new positive results should be defined in advance. Herds pursuing S. agalactiae eradication require systematic culture of all animals and repeat testing to confirm elimination.

Daily management for contagious mastitis control requires consistent attention to milking procedures and monitoring for new infections. Every milking should follow established hygiene protocols with pre-milking teat cleaning, forestripping for clinical detection, proper unit attachment and removal, and post-milking teat disinfection. Milking order should be maintained with known infected cows milked last or with dedicated equipment. Visual observation of all cows during milking identifies new clinical cases for prompt attention. Daily production records flag sudden drops that may indicate new infections. Staff training and supervision ensure protocol compliance, as lapses in any component increase transmission risk.

Housing and environmental management influence contagious mastitis primarily through effects on teat condition and cow stress. While contagious pathogens spread mainly during milking rather than from environmental contamination, housing quality affects overall udder health and immune function. Clean, dry, comfortable stalls with adequate bedding support teat health. Overcrowding increases stress and reduces time spent lying. Heat stress impairs immune function and increases susceptibility to infection. Flies can mechanically transfer S. aureus between cows and should be controlled. Holding area management including floor surfaces, space allowance, and wash pen practices affects pre-milking teat cleanliness.

Herd health programs should integrate mastitis control with comprehensive health management. The five-point mastitis control program provides the foundation: post-milking teat disinfection, appropriate treatment of clinical cases, dry cow therapy, culling chronically infected cows, and regular milking equipment maintenance. Regular veterinary herd health visits review mastitis records, culture results, and cell count trends. Treatment protocols should be established and regularly reviewed for effectiveness. Dry cow protocols including therapy selection and teat sealant use require veterinary input. Transition cow management supporting immune function reduces new infection risk during the vulnerable periparturient period.

Record keeping systems provide essential data for monitoring and managing contagious mastitis. Individual cow mastitis records including clinical episodes, culture results, treatments, and outcomes track infection status. Monthly DHIA somatic cell count data trends over time indicate program effectiveness and identify chronically infected individuals. Linear score averages and new infection rates benchmark against industry standards. Bulk tank cell counts and culture results provide herd-level monitoring. Treatment logs ensure withdrawal compliance. Culling records should capture mastitis as a contributing factor when relevant. Analysis of these records guides management decisions and documents program progress.

Economic considerations pervade contagious mastitis management decisions. Milk quality premiums and penalties based on somatic cell count provide direct financial incentive for control. Discarded milk during treatment and withdrawal represents significant cost per case. Production losses from subclinical infection accumulate throughout lactation. Treatment costs including drug purchase, labor, and veterinary fees affect individual case economics. Premature culling eliminates future productive potential and requires replacement purchase. Cost-benefit analysis of control program components helps optimize investment. Reducing herd prevalence from high to low levels typically shows strong economic returns, while achieving complete elimination of S. aureus may not be cost-effective in all situations.

All dairy cattle breeds are susceptible to contagious mastitis, with no breed showing complete resistance or dramatically elevated susceptibility. Research comparing breeds has generally found modest differences that are often confounded by management system variations between breed populations. Holstein cattle show typical susceptibility patterns and account for the majority of cases simply due to their dominance in commercial dairy production. Jersey cattle are sometimes reported to have slightly lower mastitis rates, potentially related to udder conformation, smaller body size, and lower production volume. Brown Swiss, Guernsey, and Ayrshire breeds demonstrate variable susceptibility in different studies without consistent trends.

Production type and intensity influence contagious mastitis risk more than breed per se. High-producing cows face elevated risk due to immune suppression during negative energy balance, larger udder size with greater environmental exposure, and more frequent milking that increases transmission opportunities. Cows managed in intensive confinement systems have higher S. aureus prevalence than those in pasture-based systems in many comparisons, likely reflecting both transmission dynamics and management factors. Organic and low-input systems may have different mastitis patterns than conventional operations. First-lactation heifers generally show lower contagious mastitis prevalence than multiparous cows but may acquire infections that persist through subsequent lactations.

Genetic selection offers meaningful opportunity for reducing contagious mastitis susceptibility over time. Somatic cell score is included in genetic evaluations and selection indices in most countries, allowing selection against high cell counts associated with subclinical mastitis. Clinical mastitis resistance is directly evaluated in some countries with sufficient health recording. Udder conformation traits including udder depth, udder attachment, and teat placement affect both mastitis susceptibility and milking efficiency. Selection for disease resistance must be balanced against production traits and other health characteristics. Genomic selection accelerates genetic progress by identifying favorable alleles in young animals. Within-herd selection removing chronically infected cows from the breeding population also improves genetic resistance over time.

Commonly co-occurring conditions with contagious mastitis include other mammary infections and systemic health issues. Mixed infections with multiple mastitis pathogens occur frequently, with a quarter containing both contagious and environmental organisms. Concurrent infection with coagulase-negative staphylococci may complicate culture interpretation. Teat injuries and lesions that increase susceptibility to contagious mastitis may also predispose to environmental infections. Systemic conditions impairing immune function including transition cow metabolic disorders increase vulnerability to new infections and reduce treatment response. Other infectious diseases affecting herd health may correlate with mastitis incidence through shared management deficiencies.

Conditions with similar symptoms that must be differentiated from contagious mastitis include environmental mastitis caused by streptococci, coliforms, and other organisms. Streptococcus uberis and Streptococcus dysgalactiae cause mastitis similar in presentation to S. agalactiae but with environmental rather than contagious transmission patterns. Mycoplasma mastitis is contagious and may cause herd outbreaks but requires special culture media for detection. Coagulase-negative staphylococci cause subclinical mastitis with cell count elevations but are less pathogenic than S. aureus. Udder edema in fresh cows may initially appear similar to mastitis. Culture is essential for distinguishing pathogens with different implications for treatment and control.

Complications and sequelae of contagious mastitis reflect chronic tissue damage and occasional severe presentations. Staphylococcus aureus causes progressive fibrosis of infected quarters over successive lactations, with palpable firmness and nodularity indicating scar tissue formation. Chronically infected quarters show declining production potential. Rare peracute S. aureus infections can cause gangrenous mastitis with tissue death and severe systemic illness. Abscess formation within the mammary gland may occur with S. aureus. Summer mastitis caused by Trueperella pyogenes may complicate pre-existing infections. Reduced overall productivity and shortened productive life represent the ultimate sequela of chronic contagious mastitis.